Watch the video

Rep. Peter Roskam (R-IL), chairman of the Health Subcommittee on Ways and Means, today stressed the need for Congress to reduce certain regulations on providers that “have no relationship to patient health.” 
 
The AHA has laid out actions that Congress could take to immediately reduce the regulatory burden on hospitals, health systems and the patients they serve. The proposals range from cancelling Stage 3 meaningful use requirements for electronic health records to permanently prohibiting the enforcement of direct supervision requirements in critical access and small or rural hospitals.  
 
Roskam also said that Congress is eager to hear hospital and health system leaders’ opinions on how to handle the opioid epidemic.  
 
“The institutions that you’re leading are right at the center of this, and you have a disproportionately positive influence in this debate,” Roskam said.

[For additional highlights from the AHA Annual Membership meeting, click here.] 

Roskam also addressed the issue of drug pricing, mentioning that President Trump will make an announcement in the next few days that will help “frame the debate moving forward” on the issue. 
 
“We’re not going to stay where we are,” Roskam said. “The place that we are is just completely unsatisfying.”

Related News Articles

Headline
he House of Representatives last night voted 234-183 to pass legislation (H.R. 987) that combines several AHA-supported bills to help lower prescription drug…
Headline
The Centers for Medicare…
Blog
Drug companies are at it again. And their latest effort to divert the focus from the huge profits they pocket as drug prices rise is just as disingenuous as…
Headline
The largest U.S. pharmaceutical and biotech companies spend just 22 cents out of every dollar on research and development, according to an analysis released…
Headline
The Health Resources and Services Administration yesterday awarded 120 organizations, including hospitals, $200,000 each to develop community partnerships and…
Headline
The House Energy and Commerce Subcommittee on Health today held a hearing on lowering prescription drugs prices, which focused on the drug supply chain.